Participants also saw improvements in waist circumference, blood pressure, and overall physical fitness
FDA Pharmacy Compounding Advisory Committee recommends the inclusion of six peptide substances, including BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax, on the FDA's 503A Bulks List, representing a significant step in the FDA's ongoing regulatory review process for these peptide substances
The company has emphasized its commitment to accessibility, offering patient support programs, including a lower-cost vial option, to help ease financial barriers
Food and Drug Administration issued a warning that versions of semaglutide obtained from compounding pharmacies could be dangerous